Coherus BioSciences Inc (CHRS)

Currency in USD
1.445
-0.015(-1.03%)
Real-time Data·

CHRS Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral

Technical Indicators

Neutral

Moving Averages

Buy

Summary:Neutral

Moving Averages:BuyBuy: (8)Sell: (4)
Technical Indicators:NeutralBuy: (3)Sell: (3)

Technical Indicators

Summary: NeutralBuy: 3Neutral: 5Sell: 3
Jul 28, 2026 15:46 GMT
Name
Value
Action
RSI(14)53.392Neutral
STOCH(9,6)47.209Neutral
STOCHRSI(14)42.202Sell
MACD(12,26)0.008Buy
ADX(14)27.994Buy
Williams %R-52.941Neutral
CCI(14)-10.1787Neutral
ATR(14)0.0256Less Volatility
Highs/Lows(14)0Neutral
Ultimate Oscillator46.632Sell
ROC1.399Buy
Bull/Bear Power(13)-0.013Sell

Moving Averages

Summary: BuyBuy: 8Sell: 4
Jul 28, 2026 15:46 GMT
Name
Simple
Exponential
MA5
1.449
Buy
1.447
Buy
MA10
1.455
Sell
1.446
Buy
MA20
1.436
Buy
1.442
Buy
MA50
1.427
Buy
1.444
Buy
MA100
1.466
Sell
1.448
Buy
MA200
1.470
Sell
1.480
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic1.4061.4131.4261.4331.4461.4531.466
Fibonacci1.4131.4211.4251.4331.4411.4451.453
Camarilla1.4331.4351.4371.4331.4411.4431.445
Woodie's1.411.4151.431.4351.451.4551.47
DeMark's--1.4291.4351.45--

FAQ

From a Technical Analysis Perspective, Is Coherus BioSciences a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Do the Moving Averages for CHRS Currently Stand?

The moving averages for Coherus BioSciences show a Sell outlook, considering moving averages ranging from MA5 to MA200, with 3 Buy signals and 9 Sell signals.

What Is the Current Status of the Technical Indicators for Coherus BioSciences?

The technical indicators for Coherus BioSciences are in a Strong Sell position based on daily analysis, with 1 signals on buy indicators and 6 sell signals.

What Is CHRS's 14-Day RSI?

The current Relative Strength Index (RSI) of CHRS over the 14-day period is 53.392, which suggests that the stock is a Neutral.

What Is CHRS's MACD?

CHRS's MACD is 0.008, which suggests that the stock is a Buy.

What Is CHRS's 5-Day Moving Average?

CHRS's 5-day moving average is 1.449, suggesting that the stock is a Buy.

What Is CHRS's 50-Day Moving Average?

CHRS's 50-day moving average is 1.427, suggesting that the stock is a Buy.

What Is CHRS's 200-Day Moving Average?

CHRS's 200-day moving average is 1.470, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for CHRS?

The Fibonacci pivot point performance value for CHRS is 1.433.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.